German Tech Investor Leads Series a for Germany’s First Medical Cannabis Startup

Germany just hit a new milestone in the space where venture capital and the burgeoning cannabis industry meet. Berlin startup Demecan has completed a Series A financing round of €7 million to expand its production facility for medical cannabis and the wholesale trade in Germany. It has become the only German company allowed to produce medical cannabis in Germany. This is a watershed moment for the country and is the first investment in this sector…


Go to Source

Powered by WPeMatico